Publications

Featured Manuscripts

Our publication list includes original research articles and review articles authored by members of our team, partners, and others, all of which include data or discussions relevant to our pipeline programs and technology.

TitleCategoryRelatedhf:doc_categories

The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine
Vaccine
May 2023

hepatitis-b

Cost-effectiveness of a 3-antigen versus single-antigen vaccine for the prevention of hepatitis B in adults in the United States
Vaccine
May 2023

hepatitis-b

Immunogenicity and safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine; A Phase 3 Randomized Clinical Trial
The Journal of the American Medical Association Network Open
October 2021

View Press Releasehepatitis-b

Use of eVLP-based vaccine candidates to broaden immunity against SARS-CoV-2 variants
bioRxiv
September 2021

View Press Releasecoronaviruses

An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits potent immunity after a single dose
Vaccine
July 2021

View Press Releasecoronaviruses

Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: a Phase 3 randomized clinical trial
Vaccine
June 2021

hepatitis-b

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a raondomised, double-blind phase 3 trial
The Lancet Infectious Diseases
May 2021

View Press Releasehepatitis-b

Immunogenicity of Sci-B-Vac (a Third-Generation Hepatitis B Vaccine) in HIV-Positive Adults
Israel Medical Association Journal
March 2021

hepatitis-b

Rapid and high seroprotection rates achieved with a tri-antigenic hepatitis B vaccine in healthy young adults: Results from a Phase IV Study
Vaccine
February 2021

View Press Releasehepatitis-b

Efficacy and Safety of a 3-antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 Randomized Clinical Trial in the Russian Federation
Clinical Infectious Diseases
October 2020

hepatitis-b

Prophylactic Vaccination Against Hepatitis B: Achievements, Challenges, and Perspectives
Medical Microbiology and Immunology
February 2015

hepatitis-b

Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine
Medical Microbiology and Immunology
January 2015

hepatitis-b

Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine
Vaccine
September 2014

hepatitis-b

Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity
Clinical and Vaccine Immunology
February 2014

cytomegalovirus

Randomized Controlled Study Investigating Viral Suppression and Serological Response Following Pre-S1/Pre-S2/S Vaccine Therapy Combined with Lamivudine Treatment in HbeAg-Positive Patients with Chronic Hepatitis B
Antimicrobial Agents and Chemotherapy
December 2009

hepatitis-b

PreS1 epitope recognition in nerborns after vaccination with the third-generation Sci-B-Vac™ vaccine and their relation to the antibody response to hepatitis B surface antigen
Virology Journal
January 2009

hepatitis-b

Cellular and humoral immune response to a third generation hepatitis B vaccine
Journal of Viral Hepatitis
August 2007

hepatitis-b

Comparative Immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine
Vaccine
April 2006

hepatitis-b

Improved Immunogenicity of a Novel Third-Generation Recombinant Hepatitis B Vaccine in Patients with End-Stage Renal Disease
Nephron Clinical Practice
June 2004

hepatitis-b

Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S2 and pre-S2 antigens as compared with conventional yeast-derived vaccines
Nephron Clinical Practice
June 2004

hepatitis-b

Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B™ vaccine
Medical Science Monitor
January 2004

hepatitis-b

Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates
Israel Medical Association Journal
May 2001

hepatitis-b

Rapid Seroprotection against Hepatitis B following the First Dose of a Pre-S1/Pre-S2/S vaccine
Journal of Hepatology
January 2001

hepatitis-b

Safety and Immunogenicity of a New Mammalian Cell-Derived Recombinant Hepatitis B Vaccine Containing Pre-S1 and Pre-S2 Antigens in Adults
Israel Medical Association Journal
June 1997

hepatitis-b

Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI

Sign Up Now for our newsletterArrow
Go top